Viking Therapeutics, Inc.
Industry: Life Sciences ・ $VKTX on Nasdaq
Insider Sale
+$10,296,607
-46.85%
Shares
Shares Volume: 131,687 Shares
Average Share Price: $78.19
INSIDER
ZANTE GREG
Chief Financial Officer (Officer)
reported on Oct 28 2024
traded on Oct 28 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 149,366 |
| PURCHASES/SALES 1Y | 0 / 4 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $4,123,906.92 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 0 / 22 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $3,983,990.1 |
| COMPANY PREVIOUS TRADES |